Sulfapyridine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sulfapyridine and what is the scope of patent protection?
Sulfapyridine
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for sulfapyridine.
Summary for sulfapyridine
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,516 |
| DailyMed Link: | sulfapyridine at DailyMed |
Recent Clinical Trials for sulfapyridine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assistance Publique - Hôpitaux de Paris | Phase 1/Phase 2 |
Medical Subject Heading (MeSH) Categories for sulfapyridine
Anatomical Therapeutic Chemical (ATC) Classes for sulfapyridine
US Patents and Regulatory Information for sulfapyridine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | SULFAPYRIDINE | sulfapyridine | TABLET;ORAL | 000159-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
